Literature DB >> 29126510

Long-term outcomes of pediatric inflammatory bowel disease.

Soheila Nasiri1, Mary Ellen Kuenzig2, Eric I Benchimol3.   

Abstract

The incidence and prevalence of childhood-onset inflammatory bowel diseases (IBD), including subtypes Crohn's disease and ulcerative colitis, have risen dramatically in recent years, and have emerged globally as important pediatric chronic diseases. Therefore, health care providers are more frequently encountering very young children with IBD, a chronic and incurable condition requiring life-long therapy. These children are living long lives with IBD and therefore knowledge of long-term outcomes is increasingly important to better counsel families and determine the best course of treatment. This review summarizes the current knowledge and literature surrounding long-term outcomes of pediatric IBD, with emphasis on the following areas: need for surgery due to complicated disease behavior, risk of disease remission and recurrence, mental health and psychosocial well-being, educational outcomes, linear growth impairment, cancer risk, and mortality. In addition, we review recent research about predicting negative long-term outcomes in children with IBD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Epidemiology; Inflammatory bowel diseases; Outcomes; Pediatric; Surgery

Mesh:

Substances:

Year:  2017        PMID: 29126510     DOI: 10.1053/j.sempedsurg.2017.10.010

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  6 in total

1.  Three-year outcomes of childhood inflammatory bowel disease in New Zealand: A population-based cohort study.

Authors:  Natalie G Martin; Amin J Roberts; Helen M Evans; Jonathan Bishop; Andrew S Day
Journal:  JGH Open       Date:  2020-02-07

2.  Validation of the newly FDA-approved Buhlmann fCal Turbo assay for measurement of fecal calprotectin in a pediatric population.

Authors:  Emily Garnett; Jayson Pagaduan; Deepthi Rajapakshe; Estella Tam; Richard Kellermayer; Sridevi Devaraj
Journal:  Pract Lab Med       Date:  2020-10-17

Review 3.  NLRP3 inflammasome in colitis and colitis-associated colorectal cancer.

Authors:  Agampodi Promoda Perera; Karishma Sajnani; Joanne Dickinson; Rajaraman Eri; Heinrich Körner
Journal:  Mamm Genome       Date:  2018-09-11       Impact factor: 2.957

4.  Winnie-APCMin/+ Mice: A Spontaneous Model of Colitis-Associated Colorectal Cancer Combining Genetics and Inflammation.

Authors:  Stefania De Santis; Giulio Verna; Grazia Serino; Raffaele Armentano; Elisabetta Cavalcanti; Marina Liso; Manuela Dicarlo; Sergio Coletta; Mauro Mastronardi; Antonio Lippolis; Angela Tafaro; Angelo Santino; Aldo Pinto; Pietro Campiglia; Alex Y Huang; Fabio Cominelli; Theresa T Pizarro; Marcello Chieppa
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

5.  Instrumental variable analysis using offspring BMI in childhood as an indicator of parental BMI in relation to mortality.

Authors:  Kim Blond; David Carslake; Line Klingen Gjærde; Dorte Vistisen; Thorkild I A Sørensen; George Davey Smith; Jennifer L Baker
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

6.  Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation.

Authors:  Maciej Bieliński; Natalia Lesiewska; Joanna Bielińska; Ariel Liebert; Artur Mieczkowski; Paulina Sopońska-Brzoszczyk; Bartosz Brzoszczyk; Maria Kłopocka; Alina Borkowska
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.